Amyloid beta — Drug Target

All drugs that target Amyloid beta — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Monoclonal antibody · Amyloid beta inhibitor · Amyloid beta antibody

Phase 3 pipeline (2)

• amyloid PET · National Taiwan University Hospital · Neurology
  Amyloid PET is a diagnostic imaging agent that binds to amyloid beta plaques in the brain.
• [18F]Florbetaben · Ulsan University Hospital · Neurology
  A radioligand used for the imaging of amyloid plaques in the brain.

Phase 2 pipeline (3)

• AGB101 · AgeneBio · Monoclonal antibody · Neurology
  AGB101 is a monoclonal antibody targeting amyloid-beta
• ALZ-801 · Alzheon Inc. · Amyloid beta inhibitor · Neurology
  ALZ-801 is a dual A beta 42 and A beta 40 inhibitor.
• BG00010 · Biogen · Amyloid beta antibody · Neurology
  BG00010 is a monoclonal antibody targeting amyloid beta.